Fact CheckerSign in

NCT06730438Recruiting

Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia

Transcranial Pulse Stimulation: a Potential New Treatment for Chronic Disorders of Consciousness/Cognition Due to Vegetative/Minimally Conscious States and Early Dementia

Source: ClinicalTrials.gov · Last updated 16 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Alzheimer's Disease (AD) is characterized by the absence of treatments to slow, stop, or reverse its course, with patients finally losing cognitive functions, skills and independence. It is a chronic degenerative disease with high social and medical burden worldwide: AD ranked third among neurological disorders in terms of disability-adjusted life years (DALY) rates. The primary aim of the research protocol is to improve care for patients with AD, by implementing, with an innovative method, the currently available repertoire of neuromodulation techniques. For this aim, we will investigate whether Transcranial Pulse Stimulation (TPS) may induce cognitive improvement in patients with an early stage of dementia.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
9 Dec 2024
Start date
1 Dec 2024
Primary completion date
31 May 2026
Lead sponsor
Francesca Pistoia
NCT number
NCT06730438

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Dec 2024 to the primary completion date, 31 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • medical instability interfering with standard neurological assessment
  • any contraindication to preliminary MRI for MR-based real-time neuronavigation
  • comorbidities which may interfere with cognitive status
  • any contraindication to Transcranial Pulse Stimulation.

Who the study is looking for

  • age\>18 years
  • diagnosis of early dementia according to current international guidelines
  • disease duration of at least 12 months
  • consent to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
San Salvatore Hospital
Coordinator of this site? Confirm its status
L’AquilaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.